CANADA LIFE ASSURANCE Co
InsurancePosition in SRPT — Sarepta Therapeutics, Inc.
CIK 1046192
WINNIPEG, A2
Position in SRPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,547,810
-$306,033 QoQ
Shares Held
86,133
+1.1% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $335,351,557 across 80 Biotechnology names. SRPT ranks #27 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,547,810 | 86,133 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,853,843 | 85,195 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,919,992 | 89,219 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,869,980 | 97,041 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,223,214 | 71,533 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $4,452,338 | 69,764 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,233,909 | 75,943 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,547,340 | 76,446 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,218,948 | 71,006 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,025,091 | 23,367 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,415,378 | 25,048 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,737,268 | 22,581 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,244,019 | 19,595 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,518,981 | 18,276 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,486,510 | 19,189 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,190,957 | 10,774 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $357,034 | 4,763 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $354,742 | 4,541 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $383,613 | 4,260 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $385,456 | 4,168 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,276,024 | 16,414 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $4,003,751 | 53,720 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,381,970 | 49,164 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,416,104 | 38,568 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $4,440,936 | 27,697 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,898,881 | 19,412 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||